FDA Inspection 1061150 — ATSF NW Office
The FDA completed an inspection of ATSF NW Office on Jul 9, 2018 in Eau Claire, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 9, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Eau Claire, WI (United States)